Pathogenesis of hepatocellular carcinoma: A review from the viewpoint of molecular analysis
β Scribed by Yasushi Kasai; Shin Takeda; Hiroshi Takagi
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 663 KB
- Volume
- 12
- Category
- Article
- ISSN
- 8756-0437
No coin nor oath required. For personal study only.
β¦ Synopsis
Chronic liver inflammation and hepatic regeneration by infection with hepatitis B (HBV) or C virus (HBC) seem to be important risk factors for hepatocellular carcinoma (HCC). Regarding the hepatocarcinogenesis of HBV DNA integration, it has been variously hypothesized that mechanisms such as the alteration of host chromosomal DNA and transcriptional trans-acting activity of the X gene are activated. On the other hand, integration of HCV virus into chromosomal DNA has not been reported. It is suggested that HCV could replicate more efficiently in noncancerous than in cancerous tissues. Therefore, it might affect some oncogenes or cause an inactivation of tumor suppressor genes in the early stage of HCC. Genetic alterations such as a point mutation and loss of heterozygosity are considered to be late events occurring after tumorigenesis. Regeneration of liver cells through chronic hepatitis increases the incidence of genetic alterations in hepatic cells and/or HCCs in both HBV-and HCV-infected patients. Q 1996 Wiley-Liss, Inc.
KEY WORDS: hepatocellular carcinoma (HCC), hepatitis B virus (HBV), hepatitis C
virus (HCV), integration of HBV, p53, loss of heterozygosity (LOH)
π SIMILAR VOLUMES
The dropout from the waiting list for liver transplantation among patients with hepatocellular carcinoma (HCC) is reportedly as high as 12% to 40% per year, mostly due to tumor progression. Considering the scarcity of donor organs, it would be beneficial if we could retain them within the Milan crit
## Abstract ## Background A combined antiviral and tumoricidal effect of interferon (IFN) is assumed to occur after resection or ablation of hepatocellular carcinoma (HCC). ## Methods An electronic search of the Medline, Embase and Central databases from January 1998 to October 2007 was conducte
## Abstract Liver cancers are strongly linked to hepatitis B virus (HBV) and hepatitis C virus (HCV). Egypt has the highest prevalence of HCV worldwide and has rising rates of hepatocellular carcinoma (HCC). Egypt's unique nature of liver disease presents questions regarding the distribution of HBV